Arcturus Therapeutics Holdings Future Growth

How is Arcturus Therapeutics Holdings forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

63.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:ARCT - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	313	29	-121	-94	7
12/31/2024	180	-16	-127	-85	9
12/31/2023	117	-105	-66	-59	9
9/30/2022	52	-147	-176	-171	N/A
6/30/2022	41	-165	-150	-145	N/A
3/31/2022	15	-198	-147	-141	N/A
12/31/2021	12	-204	-138	-135	N/A
9/30/2021	9	-196	-102	-99	N/A
6/30/2021	9	-163	-100	-98	N/A
3/31/2021	9	-119	-76	-74	N/A
12/31/2020	10	-72	-45	-43	N/A
9/30/2020	10	-52	-45	-44	N/A
6/30/2020	11	-38	-32	-31	N/A
3/31/2020	19	-29	-14	-13	N/A
12/31/2019	21	-26	-7	-6	N/A
9/30/2019	25	-16	-5	-5	N/A
6/30/2019	26	-13	-9	-9	N/A
3/31/2019	18	-22	-27	-26	N/A
12/31/2018	16	-22	-22	-21	N/A
9/30/2018	10	-26	-11	-10	N/A
6/30/2018	10	-25	-6	-5	N/A
3/31/2018	12	-16	0	1	N/A
12/31/2017	13	-11	-1	0	N/A
12/31/2016	20	-2	-4	-3	N/A

Earnings vs Savings Rate: ARCT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: ARCT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ARCT is expected to become profitable in the next 3 years.

Revenue vs Market: ARCT's revenue (40.1% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: ARCT's revenue (40.1% per year) is forecast to grow faster than 20% per year.